Francis Medical designed its Vanquish system with needle guidance and hands-free stabilization for vapor ablation of prostate ...

Francis Medical is heating up with a 510 (k) clearance from the FDA for its water vapor ablation therapy aimed at cancers of ...

Working with Varian, a key player in EBRT, Telix will explore how theranostics can be used more effectively by radiation oncologists to enhance patient selection and deliver targeted treatment. The ...

If you’re dealing with advanced prostate cancer, the thought of surgery might feel like a lot to take in — and that’s completely understandable. For many men facing an advanced diagnosis, surgery will ...

Stereotactic body radiotherapy delays the need for long-term androgen deprivation therapy (ADT) in many men with oligometastatic prostate cancer, a study shows.

Having a longer travel time to their treatment facility improves survival in prostate cancer patients, according to a recent study.

In a recent interview with CURE, Dr. Kai Tsao broke down current treatment advancements for patients with prostate cancer.

In this meta-analysis, researchers evaluated the use and/or prolongation of ADT in men with non-metastatic prostate cancer undergoing definitive radiotherapy. For men with prostate cancer treated with ...

Statistics show a clear spike in eight cancers in younger people, but that has brought a debate over whether many cases ever ...

About 1 in 8 men will be diagnosed with prostate cancer during their lifetime. Most of the time, diagnosis happens through ...

MELBOURNE, Australia and INDIANAPOLIS, Dec. 8, 2025 /PRNewswire/ --Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces that the first patienthas been dosed in Part 2 ...

The treatment is suitable for men whose cancer has not spread outside of the prostate gland or has spread to the area just ...